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Important events since 1966 that have helped to ad-
vance photobiology in general and photomedicine in 
particular are reviewed. More formal courses on photo-
biology are needed so' that future photo biologists and 
photodermatologists will not have to be self-taught 
about the properties and action of light. The effective-
ness of current phototherapies and their future improve-
ment are discussed. Some of the areas of photobiology 
that will impact on photomedicine in the years to come 
are ultraviolet (UV) radiation effects on the immune 
system, the light activation of enzymes as a potential 
new type of phototherapy, the d evelopment of n ew pho-
tosensitizers for phototherapy, the effects of near-UV 
radiation on cellular membranes, and, of course, the role 
of DNA damage and repair in mutagenesis and carcino-
genesis. The future is bright for photomedicine. 
I will begin my history of cutaneous photobiology in 1966 
(the earlier history has been reviewed [1]) , because that was 
the year when the photochemistry of deoxyribonucleic acid 
(DNA) and its enzymatic repair were formally introduced to 
photodermatology. I refer to the international meeting on The 
Biologic Effects of U ltraviolet Radiation (with emphasis on the 
skin) that was held in P hiladelphia in 1966 [2]. Although invited 
lectures on DNA photochemistry and DNA repair were pre-
sented, the importance of DNA to the future of photoderma-
tology was clearly not appreciated by the majority of the 
audience in 1966. In the first place, the action spectra for 
erythema d~d not seem to implicate DNA (however, see below) , 
and secondly, even today many scientists still seem not to full y 
appreciate the unique role that DNA plays in cells. However, 
in 1968 Cleaver [3] reported that skin fibroblasts from patients 
with the heritable disease xeroderma pigmentosum were defi-
cient in their capacity to perform DNA repair. (N.B., These 
patients are abnormally photosensitive, aI:1d develop skin cancer 
in sun-exposed sites at an early age. ) This and subsequent 
related studies demonstrated quite conclusively that DNA dam-
age and repai.r are very important topics for photomedicine, as 
the program for this symposium clearly confIrms. 
Although the conference in 1966 pointed the way, it was 
several years before molecular photomedicine became estab-
lish,ed. In add ition to the general expansion of knowledge and 
development of new techniques and equipment in molecular 
bioLqgy and medicine, 'a major stimulus to photomedicine h as 
been the growi ng awareness by the public that sunlight does 
more t han permit plants to grow and animals to see. The fint 
event to awaken general interest in the effects of sunlight on 
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man and his environment was the concern over the possibility 
that high flying supersonic transports (SST's) might pollute the 
stratosphere with engine exha usts, and thereby destroy th e 
ozone layer that protects the earth by greatly attenuating the 
solar ultraviolet (UV) radiation (especially those wavelengths 
shorter than about 320 nm). As a consequence, reports were 
written on the "Biological Impacts of Increased Intensities of 
Sola r Ultraviolet Radiation" [4], and in 1971 the Department 
of Transportation initiated a 4-yr study on t he possibility of 
ozone depletion by SST 's and its possible biological conse-
quences [5, 6]. 
Following close on the heels of concern over the possible 
depletion of the ozone layer by high flying aircraft, were con-
cerns over the possible destruction of the ozone layer by nuclear 
weapons testing [7], and an even more significant threat to the 
ozone layer by the chlorofluoromethanes that are used in re-
frigeration and in many types of spray cans [8, 9]. Publicity 
about these various reports not only made the general public 
aware that sunlight might have detrimental effects on man, but 
it also helped to extract some money out of various agencies to 
support some badly needed research on the effects of solar UV 
radiation on man and other organisms. 
Two important events in 1972 that h elped -to stimulate pho-
tomedicine were an international conference on photosensiti-
zation and photoprotection held in Tokyo [10], and the forma-
tion of the American Society for Photobiology [11]. 
The proceedings of the Tokyo meeting, published under the 
title of "Sunlight and Man" [10], summarized the advances in 
the field of photodermatology 8 yr after the initial conference 
in Philadelphia, and is still the most current summary of the 
field. A treatise on photo medicine, however, is in press [12]. 
Although other countries have had societies for photobiology 
for some years, it was not until 1972 that the then members of 
the U.S. National Committee on Photobiology (NAS/ NRC) 
plunged ahead and established the American Society for Pho-
tobiology. The Society is composed of 14 subdisciplines, one of 
which is photo medicine. 
The first meeting of the American Society for Photobiology 
in 1973 probably catalyzed a quantum jump in the advancement 
of photomedicine. The meeting was small, and there were not 
enough scientific papers in each of the 14 subspecialties of 
photobiology to keep each specialist busy in his/her specialty. 
As a consequence, there was a lot of session hopping and a lot 
of camaraderie on the beach; physicians talked to chemists, 
biologists, and physicists, and vice versa. Physicians were intro-
duced to the techniques and conceptual approaches used in 
research by the plant and bacterial photobiologists. Physicists, 
chemists, and engineers obtained a better understanding of the 
problems confronting physicians and biologists. The solutions 
to some of these problems were ail'eady available, and only 
awaited t he establishment of an appropriate line of communi-
cation. Friendships and interdisciplinary scientific collabora-
tions were begun at this meeting that continue today. 
PHOTOTHERAPIES 
The recent development and modernization of several types 
of phototherapies have also greatly stimulated interest in pho-
tomedicine. The first of these phototherapies was the treatment 
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by nonionIzing radiation, it is clear that light must fust be 
abso rbed in the biological system to cause the chemistry that 
causes the biological response. 
If this simple but very powerful law of photochemistry were 
to be remembered and put into use by all photo biologists, t hen 
the science of photobiology would advance even faster. For 
example, a famous photodermatologist stated at a recent meet-
ing that visible light is less "photochemically reactive" than is 
UV radiation. T he fu·st law of photochemistry would immedi-
ately te ll one that this statement is not true. It is correct that, 
in general, visible light has less of a detrimental effect on 
biological systems than does UV radiation, but this is not due 
to some unique property of visible light. Rather, it is due to the 
fact that, in cells, there are many fewer chromophores of 
biological importance that are able to absorb visible light, as 
may be confirmed by an absorption spectrum of a cell lysate. 
However, whenever visible ligh t is absorbed within a cell, 
photochemistry can and does occur. Unfortunately, many other 
common misconceptions about the properties of light still exis t 
[29, 30). 
Some problems in photodermatology have had to do with 
interpreting action spectra, and using action spectra data 
properly when the chromophore is subsequently exposed to 
polychromatic light. Because only certain of the effective wave-
lengths of light in the action spectrum for erythema are present 
in sunlight, and each of these wavelengths is present to different 
extents, the concept of the effectiveness sp ectrum was intro-
duced to photodermatology [31). The effectiveness spectrum is 
the product of the action spectrum for the biological effect and 
the emission spectrum of the polychromatic light source (Fig 
2a). The effectiveness spectrum for sunlight- induced erythema 
peaks at longer wavelengths (-310 nm) than does the action 
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F IG 2. a, The action spectrum for the production of sunburn (solid 
line), a typical spectrum of sunligh t at tbe earth 's surface (dotted line ), 
and the product of the 2 spectra, i.e., the effectiveness spectrum (dashed 
line). (b) The absorption spectrum of DNA (solid line ), . and the 
transmi.ssion spectrum of a protein that contains aro'mat ic amino acids 
(dashed line), Note that proteins ru ter out much less of the longer 
wavelengths of light that are absorbed by DNA. The product of these 
2 spectra should be the action spectrum for DNA damage in the case 
where a layer of protein lies between the light source and the DNA. 
This product spectrum (not shown) is similar to the sunburn action 
spectrum in Fig 2a [321. 
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spectrum (-297 nm) [31, 32). This result has great significance 
to those who are developing sun screens. 
Many of the problems of interpreting action spectra for skin 
reactions have resulted from not taking proper account of the 
shielding of the inner layers of the skin by the outer layers. 
These outer layers (composed mostly of proteins) absorb certain 
wavelengths of light from the light source, and therefore effec-
tively alter the spectral distribution of the light that reaches 
the inner layers of skin (Fig 2b). Thus, it has been demonstrated 
that the product of the transmission spectrum of protein and 
the absorption spectrum of DNA yields a curve that is very 
similar to the action spectrum for erythema [32]. Therefore, it 
is not improbable that the chromophore for erythema might be 
DNA. 
Still another problem is that action spectra are determined 
with essentially monochromatic radiation. Very frequently, the 
response of an organism will not follow the response predicted 
from the action spectrum, when exposed to polychromatic 
radiation. This is due, in part, to the fact that many biological 
systems respond to the different wavelengths of light in a 
nonadditive way, i.e. , the responses can be either synergistic or 
antagonistic . Many examples of radiation antagonism and syn-
ergism exist [33]. 
A related problem is the development of photochemothera-
peutic drugs in the laboratory using monochromatic or narrow-
band radiation [e.g. , 34], and then using them in the clinic with 
broad-band radiation [e.g., 27]. Frequently, different photo-
chemistry is obtained with a compound, depending upon the 
wavelengths of radiation used. This is particularly true for 
nonsymmetrical compounds that have 2 photochemically re-
active sites, as is the case for compounds like 8-methoxypsoralen 
[35). 
It is obvious that the science of photobiology will progress as 
the knowledge and expertise of photobiologists progress. To 
speed up this process, what is needed is the introduction of 
more formal courses and training programs on photobiology. 
One important s tep in this direction was the 2-week College 
Faculty Conference on Photobiology and Radiation Biology 
(July 1980) sponsored by the National Science Foundation and 
administered by the American Institute of Biological Sciences. 
It is hoped that the college teachers who participated as stu-
dents in this course will now incorporate more topics on pho-
tobiology in their existing courses, and one day may give a 
whole course on photobiology. 
THE FUTURE OF PHOTOMEDICINE 
The future progress of photomedicine, as in every other 
discipline in science and medicine, depends upon the rate of 
development of new techniques and instrumentation, of break-
throughs in basic research, and on the creative application of 
these techniques, instrumentation, and information to the prob-
lems that face mankind. There are several areas of photobiology 
that should be very important to the progress of photomedicine 
in the near future. 
Phototechnology 
Recently, there have been significant advances in the design 
and manufacture of light sources, monochromators, and fllters 
that are helping all of photobiology. The new light source that 
has caught the imagination of many people is the laser . How-
ever, headlines, both in the lay and scientific press, promise 
more magic from lasers than they can possibly deliver. After 
all , the radiation fTom a laser must still obey the laws of 
photochemistry. Although scientists and engineers throughout 
the world are trying to find unique applications for lasers in 
medicine, only a few breakthroughs have been made [28]. 
Perhaps more applications will be found in the future [36]. 
July 1981 
Photo immunology 
A new area of research that has had a very stimulat ing effect 
on photomedicine is photoimmunology, especially the immu-
nobiology of UV radiation-induced tumors [reviewed in refer-
ence 37]. If UV radiation-induced tumors are generally so 
antigenic that they cannot be transplanted to syngeneic hosts, 
the obvious question to ask is what permits the tumor to grow 
in the fIrst place. The answer is that chronic UV irradiation 
produces a systemic alteration in the animal that prevents the 
immunologic rejection of these primary tumors, or prevents the 
rejection of UV radiation-induced tumors transplanted from 
another animal of the same strain [37]. Determining the molec-
ular and cellular bases of this phenomenon should greatly 
expand our knowledge of the immune system. 
In addition, this immunological response to UV radiation 
may help to solve the riddle of why solar radiation appears to 
be involved in the development of melanomas, even though the 
site of irradiation does not always correlate with the site of 
appearance of the melanomas [38]. One hypothesis is that the 
mutagenic lesion leading to some melanomas may be produced 
by some agent other than solar radiation (either an endogenous 
or an exogenous agent), but the immunological environment 
favorable for the growth of a melanoma is produced systemi-
cally by exposure to solar radiation. 
The obvious implications of these and other immunological 
effects of UV radiation on animals and man to be discussed at 
this conference should help to reinforce our concern about the 
excessive exposure of people to sunlight. 
Light Activation of Enzymes 
Another area of research that is expanding rapidly, and one 
that I feel may eventually have a big impact on photo medicine 
stems from the observation that many enzymes are activated 
by light [39, 40]. Plants and animals perceive light by numerous 
photoreceptors other than true eyes [41 , 42]. A sensitive pho-
toreceptor must be able to receive a few photons of light, and 
then be able to amplify this signal and thereby initiate a 
photobiological response. From theoretical considera tions, en-
zymes would be a good choice as a signal amplifIer. In theory, 
one photon can activate one enzyme molecule, which can then 
process thousands of substrate molecules per minute. The 
products of the fIrst enzymatic reaction may then trigger a 
second enzymatic reaction, giving a further amplifIcation of the 
initial light signal. One example of the light activation of en-
zymes that is currently receiving much attention relates to t he 
problem of visual transduction. This process begins with the 
a bsorption of light by rhodopsin in the rod outer segment, 
which results in the activation of the enzymes GTPase and 
cyclic GMP phosphodiesterase, and ends with the hyperpolar-
ization of the cell . The bleaching of one molecule of rhodopsin 
leads to th e hydrolysis of 1000-2000 molecules of cyclic GMP 
within 100-300 ms [reviewed in reference 40). As more infor-
mation is gained about the photoactivation of enzymes, this 
may lead to the development of new types of phototherapies 
for patients who are either overproducers or underproducers of 
certain metabolites, or who may have been exposed to excessive 
levels of some toxic agent. 
Photosensitization 
I have already mentioned my concern over the past usage of 
. photochemotherapy for the treatment of herpes simplex. Since 
there exists a considerable base of knowledge on the selective 
action of photosensitizers [22, 43], there is no longer the need 
to choose a photosensitizer at random for use in phototherapy. 
In principle, photosensitizers can be tailored to do specific jobs. 
Currently several la boratories [25- 27] are trying to develop 
new photosensitizers that may be even more effective than 8-
MOP in the treatment of psoriasis, but which may have les' 
detrimental side effects. One outcome of this search for new 
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drugs for PUV A therapy has me very excited. While 8-MOP 
(Fig 1) is effective against psoriasis, it also elicits a tanning 
reaction. The new drug 3-carbethoxypsoralen (3-CPs) (Fig 1) is 
also effective against psoriasis, but produces no erythema [25]. 
This suggests that the effectiveness of a sensitizer against 
psoriasis may be unrelated to the production of erythema, and 
that the screening of drugs for t he production of erythema as a 
way of finding good drugs for treating psoriasis may be coun-
terproductive. It also suggests that if one could find out why 8-
MOP produces erythema and 3-CPs does not, exciting progress 
will be made toward understanding the age old problem in 
dermatology of what causes radiation-induced erythema. 
Effects of Near- UV Radiation on Cell Membranes 
In 1966, photodermatologists were much more concerned 
with the effects of near-UV radiation on t he membranes of cells 
and organelles than they were on its effects on DNA [2). As 
more information became available concerning the impOl·tance 
of DNA damage to cell lethality, the pendulum then began to 
swing over to the concept t hat most of the lethal effects of near-
UV radiation on cells were tluough its action on DNA [44]. 
More recently, however, it has been demonstrated that a sig-
nificant amount of the lethal effects of UV -A radiation on 
bacterial cells is through membrane damage [45). This damage 
was not generally observed in the past because th e then usual 
methods of growing and plating cells (i.e., using complex growth 
media) prevented the expression of this membrane damage. 
The response of cells in minimal growth medium to the mem-
brane damage produced by near-UV radiation is similar to their 
response to heat. If this near-UV radiation effect on membranes 
can be confirmed in mammalian cells, then it will open a new 
area of concern in terms of the overexposure of people to UV-
A radiation. For example, people heavily exposed to UV-A 
radiation might be more sensit ive to toxic envi.ronmental agents 
because their cell may be more permeable to these toxic 
agents. The study of the effects of near-UV radiation on cellular 
membranes should be an exciting area for research in t he 
coming years. 
DNA Repair, Mutagenesis and Carcinogenesis 
Largely through work on the molecular defect in xeroderma 
pigmentosum and other heri table diseases t hat render patients 
photosensitive, and studies on the photochemical reactivity of 
t he furocoumarins used in the treatment of psoriasis, the study 
of DNA repair has become a major topic in photomedicine. 
Many biochemical mechanisms are now known for the repair 
of damaged DNA [46, 47], and probably new ones still remain 
to be discovered. Although many pathways of DNA repair have 
been described, they are still not well understood, even those in 
simple bacteria. Understanding the multiple mechanisms of 
DNA repair will remain an exciting challenge in t he years to 
come. 
The fact t hat mutagenesis is largely the result of errors made 
during the repair of damaged D NA [48], and that most chemical 
carcinogens have now been shown to be mutagens [49], suggests 
that the first step toward carcinogenesis may be an error made 
during the repair (or replication) of damaged DNA. Therefore, 
the study of the molecular basis of UV radiation mutagenesis 
will continue to be an important area of interest to photoder-
matology. This prediction is reinforced by the observation t hat 
skin cells fTom patients with xeroderma pigmentosum are more 
easily mutated in vitro by UV rad iation than are cells from 
normal controls [e.g., 50). In addition, it has been shown re-
cently that there ar e multiple mechanisms for producing UV 
radiation mutagenesis [51, 52], and the implications of t his 
result need to be explored. 
It is now known that even spontaneous mutagenesis is largely 
under the control of the same DNA repair genes that control 
UV radiation mutagenesis [53]. T his suggests that spontaneous 
mutagenesis arises largely through the metabolic production of 
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lesions in DNA. Clearly, these results have relevance to the 
spontaneous induction of cancer [54]. 
The genetic predisposition to spontaneous carcinogenesis, by 
virtue of having a high spontaneous mutation rate, can occur at 
many levels. (1) A person could metabolically overproduce 
agents that are detrimental for DNA, such as the superoxide 
radical or hydrogen peroxide, both of which are normal by-
products of enzyme reactions in cells [reviewed in reference 
55]. (2) The person could be an underproducer of the enzym es 
that are the first line of defense against such normal but 
detrimental species (e.g., superoxide dismutase, peroxidase, cat-
alase, etc. ). (3) If their DNA is damaged, a person may be 
deficient in en-or-free DNA repair, or be too efficient in error-
prone DNA repair. (4) Once a transformed cell is produced, it 
may not be recognized by a defective immune system, and may 
develop into a cancer. T his hypothesis is diagramed in Fig 3. 
Therefore , patients that ' are predisposed to skin cancer, and 
even those sensitive to sunlight, may not necessarily all be 
deficient in DNA repair. It is possible, for example, that a 
person's DNA repair capacity could be normal, but he produces 
so much metabolic damage to his DNA that the added exposure 
to UV radiation saturates the capacity of his cells to perform 
DNA repair effectively and/or accurately, leading both to en-
hanced lethali ty and/or enhanced mutagenesis. 
METABOLIC PROOUCTION 
DETO XIFICATION 
• . g .. SOD. PE ROX IDASE. ttc . 
DNA DAMAGE 
ERROR - FREE REPAIR 
ERROR-PRO NE REPAIR 
or 
'R EPLICATION 
ERRORS IN 
MUTAGENESIS DN'A REPLICATION 
TRA NSFORM ED CEL L S 
IMMUNE SYSTEM 
CANCER 
F IG :J. The probable steps leading to spontaneous carcinogenesis. A 
person may be an overproduce I' of metabolites that" are tox ic to DNA, 
or an underproducer of th e enzymes that detoxify these agents. If DNA 
'is damaged and then repaired or replicated in an error-prone manner 
(e.g. , due to a genetic defect in error-free repa'ir) then mutat ion~ will be 
produced that may lead to cellula r transformation. A defective immune 
system may not recognize these transformed cells, and a cancer may 
develop. 
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CONCLUSIONS 
The science of photobiology has been both "legitimized" and 
greatly stimulated in the U.S.A. by the formation of the Amer-
ican Society for Photobiology, and the Society continues to 
prosper. There is a more general awareness by the public that 
light has both beneficial and detrimental effects [56], but many 
misconceptions about the properties of light still abound, even 
among highly educated people. Physicians are stimulating more 
basic scientists to do research in the areas of photobiology that 
directly impact on clinical problems. There is a growing sophis-
tication among clinicians about the pathologies produced by 
light, and a concerted effort is underway to refine old photo-
therapies and to develop new ones. A great deal of progress has 
occurred in photobiology and photomedicine since 1966, and 
the fu ture is bright. 
I wish to express my apprecia tion to Drs. M. A. Karasek, J. A. 
Parrish, N. J. Sargentini and T . V. Wang for their critical reading of a n 
early draft of this paper. 
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